Saturday, December 2, 2023

Danaher in the lead to acquire biomedical equipment vendor Abcam

Must read


Reuters exclusively reported that Danaher Corp (DHR.N) is in the lead to acquire Abcam Plc, a provider of supplies to life science researchers with a market value of $5.4 billion, as it expands its biomedical offerings. 

Market Impact

Abcam shares rose as much as 9% in afternoon trading in New York on Friday to $24.52. Danaher shares were up 1.3% at $256.76.

Article Tags

Topics of Interest: Deals

Type: Reuters Best

Sectors: Business & Finance

Regions: AmericasEurope

Countries: EnglandUnited States

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Important Regional Story

More articles

Leave a Reply

Latest article